Salley Amanda, Lee Martin L
Hinsdale Hospital, UChicago Medicine AdventHealth Hinsdale Hospital, Hinsdale, IL 60521, USA.
Prolacta Bioscience, City of Industry, CA 91746, USA.
Nutrients. 2024 Apr 18;16(8):1206. doi: 10.3390/nu16081206.
An exclusive human milk diet (EHMD) and standardized feeding protocols are two critical methods for safely feeding very low birth weight (VLBW) infants. Our institution initiated a standardized feeding protocol for all VLBW infants in 2018. In this protocol, a human milk fat modular was used only reactively when an infant had poor weight gain, fluid restriction, or hypoglycemia. As part of our NICU quality improvement program, internal utilization review data revealed a potential opportunity to improve growth and reduce costs. While maintaining the EHMD, a simple feeding guideline process change could provide cost savings without sacrificing caloric density or growth. We examined this process change in pre-post cohorts of VLBW infants.
Our revised feeding protocol, established in October 2021, called for a human milk fat modular (Prolact CR) to be added to all infant feeding when parenteral nutrition (PN) and lipids were discontinued. The human milk fat modular concentration is 4 mL per 100 mL feed, providing approximately an additional 2 kcal/oz. We tracked data to compare (1) the use of the human milk fat modular, (2) the use of the human milk +8 fortifier, (3) overall growth before and after feeding protocol changes, and (4) cost differences between protocols.
Thirty-six VLBW infants were followed prospectively upon the introduction of the revised feeding protocol. In the revised era, the need for human milk +8 fortifier decreased from 43% to 14%. The decrease in the cost of a more costly fortifier provided a cost savings of USD 2967.78 on average per infant. Overall growth improved from birth to discharge, with severe malnutrition declining from 3.3% to 2.7% and moderate malnutrition declining from 37% to 8%.
With the proactive use of a human milk fat modular in a standardized feeding protocol, our VLBW infants showed improved growth, lower malnutrition rates, and decreased use of higher caloric fortifiers.
纯母乳喂养(EHMD)和标准化喂养方案是安全喂养极低出生体重(VLBW)婴儿的两种关键方法。我们机构于2018年为所有VLBW婴儿启动了标准化喂养方案。在该方案中,仅在婴儿体重增长不佳、需要限制液体摄入或出现低血糖时才被动使用人乳脂肪模块。作为我们新生儿重症监护病房质量改进计划的一部分,内部使用情况审查数据显示存在改善生长和降低成本的潜在机会。在维持EHMD的同时,简单改变喂养指导流程可以在不牺牲热量密度或生长的情况下节省成本。我们在VLBW婴儿的前后队列中研究了这一流程变化。
我们于2021年10月制定的修订喂养方案要求在停止肠外营养(PN)和脂质时,在所有婴儿喂养中添加人乳脂肪模块(Prolact CR)。人乳脂肪模块的浓度为每100毫升喂养液中添加4毫升,每盎司额外提供约2千卡热量。我们跟踪数据以比较(1)人乳脂肪模块的使用情况,(2)人乳+8强化剂的使用情况,(3)喂养方案改变前后的总体生长情况,以及(4)不同方案之间的成本差异。
在引入修订后的喂养方案后,对36名VLBW婴儿进行了前瞻性跟踪。在修订后的时期,人乳+8强化剂的需求从43%降至14%。成本更高的强化剂成本降低,平均每名婴儿节省2967.78美元。从出生到出院,总体生长情况有所改善,重度营养不良从3.3%降至2.7%,中度营养不良从37%降至8%。
在标准化喂养方案中主动使用人乳脂肪模块,我们的VLBW婴儿生长情况得到改善,营养不良率降低,高热量强化剂的使用减少。